samedan logo
 
 
spacer
home > pmps > spring 2003 > editor's letter
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Editor's Letter

Plus ça change, plus c'est la même chose

Three months into the third year of the brave new millennium and I'm wondering if our fragile world is any closer to delivering the nirvana promised by exciting scientific discoveries at the turn of the decade. Is it simply the case that the more things change the more they seem the same?

What happens in life science media may be a useful paradigm for the sector as a whole. For example, in the run-up to Y2K B2B magazines, websites and events boomed on the back of 'new age' high-tech industries in electronics, IT, pharma and biotech. So much money pumped in by not-so-savvy investors looking for a piece of the action created a bubble that was ripe to burst.

A downturn in advertising revenues was the first sign of difficult times ahead - it wasn't long before media groups began downsizing, with staff lay-offs and distress sales. Recession in the wider economy followed, with 9/11 taking a lot of the blame.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Rebecca Cavalôt
spacer
Dr Patricia Lobo
spacer
spacer
spacer
Rebecca Cavalôt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

FUJIFILM Irvine Scientific Begins Customer Qualification of European Manufacturing Facility

SANTA ANA, California, September 29, 2021: FUJIFILM Irvine Scientific, Inc., today announced that it completed construction and started the commissioning phase of its new manufacturing facility in Tilburg, the Netherlands. The commissioning milestone marks the beginning of validating the facility and equipment in anticipation of full operations starting in late 2021.
More info >>

White Papers

The Importance of Critical Temperatures in the Freeze Drying of Pharmaceutical Products

Biopharma Group

Every formulation has a critical temperature, below which it should be cooled for complete solidification and maintained below during primary drying in order to prevent processing defects. To design a freeze drying cycle on a rational basis such information should be identified.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement